Literature DB >> 12551752

Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons.

Suizhen Lin1, Xing Wei, Yong Xu, Chong Yan, Richard Dodel, Yuqin Zhang, Junyi Liu, James E Klaunig, Martin Farlow, Yansheng Du.   

Abstract

Neurotoxicity induced by 6-hydroxydopamine (6-OHDA) is believed to be due, in part, to the production of reactive oxygen species (ROS). Anti-oxidants by inhibiting free radical generation, protect neurons against 6-OHDA-induced neurotoxicity. In this study, we investigated whether or not minocycline, a neuroprotective compound, could directly protect neurons against 6-OHDA-induced neurotoxicity and inhibit 6-OHDA-induced free radical production in cultured rat cerebellar granule neurons (CGN). We now report that exposure of CGN to 6-OHDA (100 microM) resulted in a significant increase in free radical production with death of 86% of CGN. Pretreatment with minocycline (10 microM) for 2 h prevented 6-OHDA-induced free radical generation and neurotoxicity. Furthermore, minocycline also attenuated H(2)O(2)-induced neurotoxicity. Our results suggest that minocycline blocks 6-OHDA-induced neuronal death possibly by inhibiting 6-OHDA-induced free radical generation in CGN. Both the antioxidative and neuroprotective effects of minocycline may be beneficial in the therapy of Parkinson's disease and other neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551752     DOI: 10.1016/s0024-3205(02)02442-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

Review 1.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

Review 2.  MPTP mouse models of Parkinson's disease: an update.

Authors:  Gloria E Meredith; David J Rademacher
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

3.  Minocycline ameliorates D-galactose-induced memory deficits and loss of Arc/Arg3.1 expression.

Authors:  Xu Li; Fen Lu; Wei Li; Jun Xu; Xiao-Jing Sun; Ling-Zhi Qin; Qian-Lin Zhang; Yong Yao; Qing-Kai Yu; Xin-Liang Liang
Journal:  Mol Biol Rep       Date:  2016-08-06       Impact factor: 2.316

4.  Minocycline protects against oxidative damage and alters energy metabolism parameters in the brain of rats subjected to chronic mild stress.

Authors:  Gislaine Z Réus; Helena M Abelaira; Amanda L Maciel; Maria Augusta B Dos Santos; Anelise S Carlessi; Amanda V Steckert; Gabriela K Ferreira; Samira D De Prá; Emilio L Streck; Danielle S Macêdo; João Quevedo
Journal:  Metab Brain Dis       Date:  2014-08-13       Impact factor: 3.584

5.  Effects of minocycline on Fas-mediated fulminant hepatitis in mice.

Authors:  Heng-Cheng Chu; Yi-Ling Lin; Huey-Kang Sytwu; Shin-Hua Lin; Ching-Len Liao; You-Chen Chao
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

6.  Transferability of oxytetracycline (OTC) from feed to carp muscle and evaluation of the antibiotic effects on antioxidant systems in liver and kidney.

Authors:  Antonia Concetta Elia; Valentina Ciccotelli; Nicole Pacini; Ambrosius Josef Martin Dörr; Marilena Gili; Mauro Natali; Laura Gasco; Marino Prearo; Maria Cesarina Abete
Journal:  Fish Physiol Biochem       Date:  2014-01-05       Impact factor: 2.794

7.  Paraquat-induced oxidative stress in drosophila melanogaster: effects of melatonin, glutathione, serotonin, minocycline, lipoic acid and ascorbic acid.

Authors:  Ernesto Bonilla; Shirley Medina-Leendertz; Virginia Villalobos; Leunardy Molero; Aquiles Bohórquez
Journal:  Neurochem Res       Date:  2006-11-04       Impact factor: 3.996

8.  Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline.

Authors:  Liliana B Menalled; Monica Patry; Natalie Ragland; Phillip A S Lowden; Jennifer Goodman; Jennie Minnich; Benjamin Zahasky; Larry Park; Janet Leeds; David Howland; Ethan Signer; Allan J Tobin; Daniela Brunner
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

Review 9.  Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding.

Authors:  Wendy Noble; Claire J Garwood; Diane P Hanger
Journal:  Prion       Date:  2009-04-21       Impact factor: 3.931

Review 10.  Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.

Authors:  Vanesa Sanchez-Guajardo; Christopher J Barnum; Malú G Tansey; Marina Romero-Ramos
Journal:  ASN Neuro       Date:  2013-04-30       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.